Evidence map›Paper›PMID 31437231›Full record

ArticlePloS one2019

Prediction model for cardiovascular events or all-cause mortality in incident dialysis patients.

Daijo Inaguma, Daichi Morii, Daijiro Kabata, Hiroyuki Yoshida, Akihito Tanaka, Eri Koshi-Ito, Kazuo Takahashi, Hiroki Hayashi, Shigehisa Koide, Naotake Tsuboi and 3 more

Abstract readMulticenter Study
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Daijo InagumaDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.ORCID 0000-0002-3977-5933
Daichi MoriiDepartment of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.
Daijiro KabataDepartment of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.
Hiroyuki YoshidaDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Akihito TanakaThe Aichi Cohort Study of Prognosis in Patients Newly Initiated into Dialysis (AICOPP) Group, Aichi, Japan.
Eri Koshi-ItoDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Kazuo TakahashiDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Hiroki HayashiDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Shigehisa KoideDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Naotake TsuboiDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Midori HasegawaDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Ayumi ShintaniDepartment of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.
Yukio YuzawaDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Some variables including age, comorbidity of diabetes, and so on at dialysis initiation are associated with patient prognosis. Cardiovascular (CV) events are a major cause of death, and adequate models that predict prognosis in dialysis patients are warranted. Therefore, we created models using some variables at dialysis initiation. We used a database of 1,520 consecutive dialysis patients (median age, 70 years; 492 women [32.4%]) from a multicenter prospective cohort study. We established the primary endpoint as a composite of the incidence of first CV events or all-cause death. A multivariable Cox proportional hazard regression model was used to construct a model. We considered a complex and a simple model. We used area under the receiver operating characteristic curve (AUROC) to assess and compare the predictive performances of the prediction models and evaluated the improvement in discrimination using the complex model versus the simple model using net reclassification improvement (NRI). We then assessed integrated discrimination improvement (IDI) to evaluate improvements in average sensitivity and specificity. Of 392 deaths, 152 were CV-related. Totally, 506 CV events occurred during the follow-up period (median 1,285 days). Finally, 692 patients reached the primary endpoint. Baseline data were set at dialysis initiation. AUROC for the primary endpoint was 0.737 (95% confidence interval [CI], 0.712-0.761) in the simple model and 0.765 (95% CI, 0.741-0.788) in the complex model. There were significant intergroup differences in NRI (0.44; 95% CI, 0.34-0.53; p < 0.001) and IDI (0.02; 95% CI, 0.02-0.03; p < 0.001). We prepared a Shiny R application for each model to automatically calculate the predicted occurrence probability (https://statacademy.shinyapps.io/App_inaguma_20190717/). The complex model made more accurate predictions than the simple model. However, the intergroup difference was not significant. Hence, the simple model was more useful than the complex model. The tool was useful in a real-world clinical setting because it required only routinely available variables. Moreover, we emphasized that the tool could predict the incidence of CV events or all-cause mortality for individual patients. In the future, we must confirm its external validity in other prospective cohorts.

Indexed as

AgedArea Under CurveCardiovascular DiseasesDiabetes ComplicationsDiabetes MellitusFemaleHumansHypoglycemic AgentsMaleMiddle AgedPrognosisProportional Hazards ModelsProspective StudiesRenal DialysisRenal Insufficiency, ChronicRisk AssessmentHypoglycemic Agents

Identifiers

PMID31437231
PMCPMC6705850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.